Voyager Therapeutics to Participate in Upcoming Investor Conferences
August 10 2021 - 4:20PM
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company
developing life-changing treatments and next-generation platform
technologies, today announced that it will participate in the
following upcoming virtual investor conferences.
- Wedbush PacGrow Healthcare Conference, panel discussion, August
11, 2021, 8:35 AM ET.
- Canaccord Genuity Growth Conference, fireside chat, August 12,
2021, 10:30-10:55 AM ET.
The sessions may be accessed from the Investors & Media
section of Voyager’s website at www.voyagertherapeutics.com.
Replays of the webcasts will be archived on the Company's website
for at least 30 days.
About Voyager TherapeuticsVoyager Therapeutics
(Nasdaq: VYGR) is leading the next generation of AAV gene therapy
to unlock the potential of the technology to treat devastating
diseases. Proprietary capsids born from the Company’s TRACER™
screening platform are powering a rich early-stage pipeline of new
and second-generation programs and may elevate the field to
overcome the limitations of conventional gene therapy vectors
across neurological disorders and other therapeutic areas.
voyagertherapeutics.com LinkedIn Twitter
Investor
Inquiries: investors@voyagertherapeutics.com
Media
Inquiries: Scott
Santiamossantiamo@voyagertherapeutics.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2023 to Apr 2024